ELEXIR is the treatment device for migraine by applying
charge-balanced, symmetric pulsed nerve stimulation to the trigeminal nerves to relieve the attack intensity and to reduce the attack frequency.
It is an FDA Class II medical device with CE certification. The device offers a daily preventive mode (20 minutes of use) and an acute mode (60 minutes of use) for when a migraine occurs.
We are a medical technology R&D startup specializing in the research and development of wearable personal medical devices, based on the concept of electroceuticals, aimed at treating various chronic diseases.
We are engaged in research and development targeting a variety of indications such as macular degeneration, migraines, facial nerve paralysis, brain developmental disorders, tinnitus, and cancer.
This is achieved by directly delivering physical stimulation to the body, which regulates neural activity, induces the regeneration of damaged tissues, and inhibits the uncontrolled proliferation of cells.